Latest Breaking News On - Georgea sisson - Page 1 : vimarsana.com

Samir Mody as chief commercial officer, while  Friedrich Asmus signs on as SVP, clinical development and medical affairs. Meanwhile, the company has also tapped  Joel Centeno as SVP, manufacturing, quality and supply chain. Mody comes over from Medtronic, where he was vice president, CRHF strategy, health economics and reimbursement. Asmus previously served as VP of clinical development at ophthalmology biotech ProQR Therapeutics, while Centeno comes over after stints at Boston Scientific, Hologic and AltheaDx. > Antios Therapeutics has tapped  Tamra Adams as chief financial officer, a newly created executive position at the company. Before joining Antios, Adams founded Accounting Concepts, which provided CFO, accounting, and financial services to emerging growth companies in the biopharmaceutical and information technology industries, including Engage Therapeutics.

United statesUnited kingdomMatteo levisettiAeglea biotherapeuticsFraiser kansteinerFriedrich asmusTamra adamsMcdavid stilwellZimmer biometPharmas rocheRockley photonicsBridget okeeffeRobert kernPeter calveleyNatalie hollesSaurabh saha